Literatuur
Aguanho, W. D. (1974) Interpretation of results in terms of carcinogenic potential to the test animal: The regulatory point of view. In:Carcinogenesis testing of chemicals (Galberg, L., Ed.) CRC Press, Cleveland, Ohio.
Ames, B. N., J. Mccann enE. Yamasaki (1975) Methods for detecting carcinogens and mutagens with theSalmonella/mammalian chromosome mutagenicity test.Mut. Res. 31, 347.
Bridges, B. A. (1976) Short term screening tests for carcinogens.Nature 261, 36, 195.
Bridges, J., enJ. R. Fry (1978) The predictive value of biochemical tests for carcinogenicity. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.
Brown, C. C. (1978) Statistical aspects of extrapolating of dichotomous dose-respons data.J. Natl. Cancer Inst. 60, 1, 101.
Carter, R. L. (1978) Long-term test for carcinogenicity — The pathologist's view. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.
Cobon, A. M., L. J. Lilly enM. F. Newton (1978) Development of a technique for rapid screening of chemicals for carcinogenicity.Brit. J. Pharmacol. 32, 3, 455P.
Comité des Spécialités pharmaceutiques (1978)Securité des médicaments,agim 78/810.
Conning, D. M. (1978) The economics of carcinogenicity testing. In:Carcinogeniticy testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.
Druckrey, H., R. Preussmann, S. Ivankovic enD. Schmähl (1967) Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitrosoverbindungen an BDRatten.Z. Krebsforsch. 69, 103.
Eckardt, R. E. (1976) Extrapolating from animals to man: Carcinogenesis.J. Occup. Med. 18, 7, 492.
Emmelot, P., enE. Scherer (1977) Multi-hit kinetics of tumor formation, with special reference to experimental liver and human lung carcinogenesis and some general conclusions.Cancer Res. 37, 1702.
Friedman, L. (1973)Problems of evaluating the health significance of the chemicals present in foods. Proceedings of the 5th International Congress of Pharmacology, San Francisco, 2, 30, Karger, Basel.
Golberg, L. (1974)Carcinogenesis testing of chemicals, Editorial. CRC Press, Cleveland, Ohio.
Green, M. H. L. (1978) The predictive value of microbiological tests for carcinogenicity. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.
IARC (1973) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some inorganic and organometallic compounds, Vol. 2. IARC/WHO, Lyon.
IARC (1974) Monographs on the evaluation of carcinogenic risk of chemicals to man,Sex hormones, Vol. 6. IARC/WHO, Lyon.
IARC (1975) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some aziridines, N-, S-& O-mustards and selenium, Vol. 9. IARC/WHO, Lyon.
IARC (1976) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some naturally occuring substances, Vol. 10. IARC/WHO, Lyon.
IARC (1977) Monographs on the evaluation of carcinogenic risk of chemicals to man,Some miscellaneous pharmaceutical substances. Vol. 13. IARC/WHO, Lyon.
Ivankovic, S. (1977) Entstehung karzinogener Nitrosoverbindungen im Magen.Med. Klin. 72, 9, 366.
Jones, G. (1978) Problems facing the regulatory authorities. In:Carcinogenicity testing: Principles and problems (Dayan, A. D.,enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.
Kolata, G. B. (1976) Chemical carcinogens: Industry adopts controversial quick tests.Science, 192, 1215.
Maes, R. A. A. (1976) Collegedictaat toxicologie, deel 1, Utrecht.
Mantel, N., enW. R. Bryan (1961) Safety testing of carcinogenic agents.J. Natl. Cancer Inst. 27, 455.
Miller, E. C., J. A. Miller enM. Enomoto (1964) The comparative cancerogenicities of 2-acetylaminofluorene and its N-hydroxy-metabolite in mice, hamsters and guinea pigs.Cancer Res. 24, 2084.
Miller, J. A. (1970) Carcinogenesis by chemicals: An overview.Cancer Res. 30, 3, 559.
Montesano, R. (1978) The use of mutagenicity tests in screening chemical carcinogens. In:Prog. Biochem. Pharmacol. 14, 157, Karger, Basel.
Mulder, G. J. (1978) Ontstaan en aantonen van carcinogene en mutagene metabolieten.Pharm. Weekblad 113, 637.
Muul, I., A. F. Hegyeli, J. C. Dacre enG. Woodard (1976) Toxicological testing dilemma.Science 193, 834.
Peck, H. M. (1974) Design of experiments to detect carcinogenic effects of drugs. In:Carcinogenesis testing of chemicals (Golberg, L., Ed.) CRC Press, Cleveland, Ohio.
Pott, P. (1918) Chirurgical observations relative to the cancer of the scrotum, 1775. Reprinted inNatl. Cancer Res. 3, 1.
Roe, F. J. C. enM. J. Tucker (1973) Recent developments in the design of cancerogenicity tests on laboratory animals.Proc. Europ. Soc. Study Drug Toxicity 15, 171.
Ruser, H. J. P. (1971) Chemical carcinogenesis.New Engl. J. Med. 283, 13, 721.
Sarma, D. S. R. (1974) Chemical interaction measurements. In:Carcinogenesis testing of chemicals (Golberg, L., Ed.) CRC Press, Cleveland, Ohio.
Slater, E. E., M. D. Anderson enH. S. Rosenkranz (1971) Rapid detection of mutagens and carcinogens.Cancer Res. 31, 970.
Stevenson, D. E., E. Thorpe enP. F. Hunt (1978) The predictive value or otherwise of conventional carcinogenicity studies. In:Carcinogenicity testing: Principles and problems (Dayan, A. D., enR. W. Brimblecombe, Eds.) MTP Press, Lancaster.
Tomatis, L., C. Agthe, H. Bartsch, J. Huff, R. Montesano, R. Saracci, E. Walker enJ. Wilbourn (1978) Evaluation of the carcinogenicity of chemicals: A review of the program of the IARC.Cancer Res. 38, 4, 877.
Vos, D. De (1978) Platina-complexen als geneesmiddel tegen kanker.Chem. Weekblad 74, 713.
Weil, C. S. (1972) Statistics versus safety factors and scientific judgement in the evaluation of safety for man.Toxicol. Appl. Pharmacol. 21, 454.
Weisburger, E. K. (1977) Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents.Cancer 40, Suppl. 1977, 1935.
Weisburger, K. A. (1975) A critical evaluation of the methods used for determining carcinogenicity.J. Clin. Pharmacol., 1, 5.
Weinstein, B. (1974) Tissue culture techniques. In:Carcinogenesis testing (Golberg, L., Ed.) CRC Press, Cleveland, Ohio.
Wetgeving betreffende geneesmiddelen, Uitvoeringsvoorschriftenci-iia, 43, Vermande Zonen, IJmuiden. 45. WHO Scientific Group on Guidelines for evaluation of drugs for use in man (1975) WHOTechn. Rep. Ser., No. 563.
WHO (1969) Scientific Group on Principles for the testing and evaluation of drugs for cancerogenicity, WHOTechn. Rep. Ser., No. 246.
Yamagiwa, K.,enK. Ichikawa (1918) Experimental study on the pathogenesis of carcinoma.J. Cancer Res. 3, 1.
Additional information
Naar een scriptie geschreven onder verantwoordelijkheid van Prof. Dr. R. R. R.Maes, hoogleraar Toxicologie te Utrecht.
Rights and permissions
About this article
Cite this article
Van Kollenburg, C.P.A.H.M. Carcinogene effecten van geneesmiddelen. Pharmaceutisch Weekblad Scientific Edition 2, 317–330 (1980). https://doi.org/10.1007/BF02273007
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02273007